(Q33368176)

26 July 2017

1 reference

title

Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

Millward PM

1

1 reference

26 July 2017

Bandarenko N

2

1 reference

26 July 2017

Chang PP

3

1 reference

26 July 2017

Stagg KF

4

1 reference

26 July 2017

Afenyi-Annan A

5

1 reference

26 July 2017

Hay SN

6

1 reference

26 July 2017

Brecher ME

7

1 reference

26 July 2017

publication date

1 September 2005

1 reference

26 July 2017

1 reference

26 July 2017

volume

45

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

1481-1486

1 reference

Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Rituximab therapy for refractory thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Rituximab in patients with refractory thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00560.X

10.1111/J.1537-2995.2005.00560.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference